These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6668667)

  • 1. [Concept of therapeutic ratio by combination of radiotherapy and chemotherapy].
    Tanaka Y
    Gan No Rinsho; 1983 Oct; 29(13):1579-83. PubMed ID: 6668667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The problems of combining chemotherapy and radiotherapy].
    Tanaka Y; Hasegawa T; Akagi K; Kato T
    Gan No Rinsho; 1987 Oct; 33(13):1664-72. PubMed ID: 3694800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic ratio in combined radio-chemotherapy--radiobiological considerations].
    Sasaki T
    Gan No Rinsho; 1983 Oct; 29(13):1584-93. PubMed ID: 6668668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
    Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
    Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen delivery: implications for the biology and therapy of solid tumors.
    Rockwell S
    Oncol Res; 1997; 9(6-7):383-90. PubMed ID: 9406244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
    Akagi K; Sogawa M; Tanaka Y
    Gan No Rinsho; 1983 Oct; 29(13):1613-8. PubMed ID: 6668669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E; Soria JC; Armand JP
    Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
    Myhr G
    Med Hypotheses; 2008; 70(3):665-70. PubMed ID: 17765401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
    Lew YS; Kolozsvary A; Brown SL; Kim JH
    Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy.
    Chen T; Li D; Fu YL; Hu W
    Chin Med J (Engl); 2008 Feb; 121(4):363-8. PubMed ID: 18304471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS
    Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trial of radiation and cisplatin, carboplatin combination chemotherapy for advanced cancer (W-platinum chemoradiotherapy].
    Kato M; Akimoto S; Akimoto K; Matsui H; Itokawa Y; Tatsuta K; Tanaka T; Komatsu T; Nakaoka Y; Miyata K; Okada H; Genno M; Sekikawa S; Takada A; Kizu O; Okuyama C; Maeda T
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):723-7. PubMed ID: 9126311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.